Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
GSS Announcements
$4.4m R&D Tax Incentive Received
GSS
GENETIC SIGNATURES LIMITED
Market sensitive
$4.4m R&D Tax Incentive Received
Date and time
17 November 2025 at 7:26 pm
Announcement type
Company Administration
Show details
Hide details
Category
Other
Report codes
12008
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
GSS announcement history
Recent GSS announcements
Commercial Testing Commences at Hvidovre Hospital in Denmark
Quarterly Activities/Appendix 4C Cash Flow Report
Becoming a substantial holder from BDX
GSS responds to the BCAL Diagnostics Announcement
BDX: BCAL to Acquire Shares in Genetic Signatures
Ceasing to be a substantial holder